CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations – ABC News

The Centers for Disease Control and Prevention director signed off on the recommendation that all Americans aged 6 months and older receive the updated COVID booster on Tuesday amid rising cases and hospitalizations across the country. Source: CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations – ABC News

Click here to continue!

COVID-19 Vaccination and Boosting During Pregnancy Benefits Pregnant People and Newborns

Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings recently published in Vaccine. The paper describes results from the Multisite Observational Maternal and Infant Study for COVID-19 (MOMI-VAX), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Source: COVID-19 Vaccination and Boosting During Pregnancy Benefits Pregnant People and Newborns

Click here to continue!

Protect Your Child from COVID-19, the Flu, and Other Illnesses | CDC

COVID-19-SM-1200px

What You Need to Know During the school year, kids tend to get sick more often — and spread germs to their friends and classmates. COVID-19 can cause serious health problems, so it’s more important than ever to protect your child’s health. You can help your child stay healthy and protect the people around them all school year long. Read the Guide: Protect Your Child from COVID-19, the Flu, and Other Illnesses | CDC

Click here to continue!

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine | FDA

Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.“Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV,” said PeterContinue…

Click here to continue!

The Potential and Challenges of Mucosal COVID-19 Vaccines | NIH: National Institute of Allergy and Infectious Diseases

In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.Although vaccines currently available for COVID-19 are usually effective at preventing severe disease, hospitalizations and death, researchers recognize the need for improvement. A vaccine more effective at preventing transmission or infection with SARS-CoV-2 couldContinue…

Click here to continue!

Polio cases in Africa linked to new oral vaccine | Science | AAAS

Last week, the Global Polio Eradication Initiative (GPEI) reported seven children, six in the Democratic Republic of the Congo (DRC) and one in neighboring Burundi, had recently been paralyzed by poliovirus strains derived from a vaccine meant to prevent the disease. Unfortunately, such cases are so common—786 were reported last year in Africa, Yemen, and elsewhere—that these seven might not have stood out against the noise. But there was a key difference, GPEI said inContinue…

Click here to continue!

NOT-AI-23-031: Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine

Coccidioidomycosis, more commonly known as Valley fever, is a fungal infection of increasing public health concern in the United States. Clinical manifestations range from mild flu-like disease to severe disseminated infection that can require life-long therapy. Valley fever is most common to the arid regions of the southwestern United States, Mexico and Central and South America. In 2019, more than 20,000 cases were reported to the Centers for Disease Control and Prevention (CDC), and thisContinue…

Click here to continue!

Seoul donates next-gen Covid jabs

The Republic of Korea has donated over 500,000 doses of the bivalent Pfizer Covid-19 vaccine to Thailand to mark the 65th anniversary of diplomatic relations between the two countries.The donation means that for the first time since vaccine rollouts began, Thailand has access to the updated Covid-19 vaccine, which targets both the original variant of the virus, as well as its subsequent mutations. Source: Seoul donates next-gen Covid jabs

Click here to continue!